Zoetis Appoints James Saccaro as Executive Vice President, CFO and COO

Zoetis announced the appointment of James Saccaro to the newly created role of Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Mr. Saccaro, previously the CFO of GE HealthCare, will succeed Wetteny Joseph, who will transition to an advisory role until early 2027 to ensure a smooth transition.

Key Details

• New Role & Responsibilities: Mr. Saccaro will lead Zoetis' global finance function and oversee Global Manufacturing and Supply. His appointment is effective August 17, 2026.
• Compensation Package: Includes a $1,000,000 annual base salary, a target annual bonus of 100% of base salary, and a $5,000,000 annual target long-term incentive award. He will also receive one-time make-whole awards totaling $7.5 million ($6.25M in RSUs and $1.25M in cash).
• CFO Transition: Outgoing CFO Wetteny Joseph will remain with the company as a Special Advisor to the CEO until February 28, 2027, to facilitate the transition. His departure was not due to any disagreement with the company.